Abstract Although elevated blood pressure is an important predictor of cardiovascular disease and stroke in the elderly, little information exists on the distribution and risk factor correlates of blood pressure in this group. As part of the Cardiovascular Health Study, a population-based cohort study of 5201 men and women aged 65 to 101 years, we investigated correlates of systolic and diastolic blood pressure. Multiple regression analyses were conducted for all participants and a subgroup of 2482 without coronary heart disease and not on antihypertensive therapy (the "healthier" subgroup). In the total group, independent predictors of diastolic blood pressure included heart rate, aortic root dimension, creatinine, hematocrit, alcohol use, and black race (positive associations) and internal carotid artery wall thickness, mitral early/late peak flow velocity, white blood cell count, cigarette smoking, and age (negative associations). Positive predictors of systolic blood pressure included mitral late peak flow velocity, left ventricular mass, common carotid artery wall thickness, serum albumin, factor VII, diabetes, alcohol use, and age; negative predictors were coronary heart disease, uric acid, height, and smoking. In the healthier subgroup, positive predictors of diastolic blood pressure included heart rate, hematocrit, serum albumin, creatinine, and body weight, whereas mitral early/ late peak flow velocity, serum potassium, smoking, and age inversely related to diastolic pressure. For the same group, common carotid artery wall thickness, left ventricular mass, serum albumin, factor VII, high-density lipoprotein cholesterol, and age were directly related to systolic blood pressure, whereas serum potassium was inversely related. Both systolic and diastolic pressures varied considerably by geographic site. Thus, in the elderly blood pressure is associated with a variety of factors as previously reported in younger populations and also with cardiovascular disease status, subclinical disease, and several blood chemistry variables not previously reported. and diastolic blood pressure (DBP) have been established as independent risk factors for increased morbidity and mortality from cardiac failure, cerebral arterial hemorrhage or occlusion, aortic aneurysms, coronary heart disease (CHD), and renal failure in both middle-aged and older adults. that of 1990, the magnitude of the problem of hypertension in the elderly is expected to increase.
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It is important to delineate the distribution and determinants of BP in older adults so that appropriate strategies for further research in the prevention of morbidity and mortality can be developed. Furthermore, because most current information on the association between elevated BP and other risk factors and abnormalities has been obtained in middle-aged populations, their significance in older adults needs further elaboration. For example, left ventricular hypertrophy (LVH) is a major complication of hypertension, and the probability of sudden death increases manyfold in hypertensive patients with this condition. 6 However, although the prevalence of LVH in hypertensive patients increases with age and level of BP, there is a paucity of information on the relation of LVH and other cardiac structural and functional measures to BP in older adults.
The Cardiovascular Health Study (CHS) is a community-based cohort study of individuals 65 years and older at baseline. It provides an opportunity for the examination of correlates of BP in older adults, especially as it relates to noninvasive measures of the heart and carotid arteries, and prevalent cardiovascular disease. In this article we present results from the cross-sectional evaluation of the distribution and correlates of BP in the CHS.
Methods

The Cardiovascular Health Study
The CHS cohort was selected from Medicare eligibility lists from four geographic areas in the United States: Allegheny County (Pittsburgh), Pa; Forsyth County, NC; Sacramento County, Calif; and Washington County, Md. Eligible people included all community-dwelling, noninstitutionalized people aged 65 years and older who were able to participate in all baseline examination procedures, who expected to remain in the denned geographic area for at least 3 years, and who were not under treatment for cancer. People with prevalent cardiovascular disease were not excluded. Details of the study objectives and design 8 and recruitment of the study cohort 9 have been previously described. Briefly, individuals were first interviewed in their homes to further determine eligibility, obtain informed consent, and obtain information on medical and personal history, medication use, functional status, quality of life, physical activity, social support, and social network. Eligible and consenting participants later reported to the CHS field center clinics after a 12-hour overnight fast for assessment of BP, heart rate, and other measures.
Seated Blood Pressure Measurements
The seated BP measurement protocol was based on the American Heart Association recommendations. 10 An appropriately sized cuff was selected from a chart of arm circumference measurements and corresponding cuff sizes, and the maximal inflation level was determined using a standard mercury sphygmomanometer while the radial pulse was palpated. After 5 minutes of seated rest, two measurements were obtained in the right arm, 1 minute apart, using a random-zero sphygmomanometer (model 7076, Hawksley & Sons Ltd, Sussex, England). The cuff was deflated at the rate of 2 mm Hg/s. SBP was defined as the first regular Korotkoff sound heard and DBP as the last regular sound heard (Korotkoff phase V). All readings were recorded to the nearest even digit, and the average of the two measurements defined the BP values used for analyses. Between the two readings, the participant's arm was held vertically at his or her side for 5 seconds, and another 25 seconds elapsed before the second measurement. Heart rate was determined by palpating the radial pulse over the right arm for 30 seconds before the BP measurements started.
Before the baseline examination began, all field center clinic supervisors were trained using this standardized protocol. Individual field center technician training followed, including a videotape demonstrating the methodology, a written test, and a series of audiotape tests. Technician training was assessed during a live performance of the BP methodology with simultaneous technician/supervisor BP measurements that were repeated every other month.
Other Measurements
Data collection was performed according to standard protocols by personnel trained and certified by the CHS Coordinating Center. The procedures have been previously described. 8 Briefly, prevalent disease was ascertained by selfreport, and whenever possible, confirmatory evidence was sought from one or more sources (eg, electrocardiography [ECG] , echocardiography, prescription medication, ankle-arm SBP ratio, hospital discharge diagnoses, and medical reports obtained from participants' physicians using standard questionnaires"). Twelve-lead resting electrocardiograms were obtained, and ECG data were analyzed at a central laboratory using the Novacoder ECG measurement and classification system. 12 M-mode, two-dimensional, and Doppler echocardicgraphic examinations were performed with the Toshiba SSH-160A (Toshiba America, Tustin, Calif) equipped with 2.5-and 3.75-MHz transducers. 13 Duplex ultrasonography of the extracranial carotid arteries was performed with a Toshiba SSA-270A equipped with a 5.0-MHz transducer.
14 Percent stenosis of the extracranial internal carotid arteries was estimated using both image and Doppler data. Doppler peak systolic flow velocities less than 1.5 m/s were assumed to indicate the absence of significant (50%) lumen stenosis. Gray-scale imaging data alone were then used to estimate percent diameter stenosis as absent (0%), mild (1% to 24%), or moderate (25% to 49%). Doppler peak flow velocities of 1.5 to 2.5 m/s were taken to represent stenosis of 50% to 74%, and Doppler flow velocities of 2.5 m/s or greater indicated 75% to 99% stenosis. The last category included totally occluded internal carotid arteries. Other measurements included height and weight, as well as waist and hip circumferences. Blood samples were drawn for measurements of lipids, hematology, chemistry, and hemostasis studies at a central laboratory.
Statistical Analyses
Mean levels of DBP and SBP were examined by selected participant characteristics. In univariate analysis, the twosample t test was used to compare BP values for variables with two categories, and the one-way analysis of variance was used for multicategorical variables. Only values of P<.01 were considered statistically significant.
To examine which variables were associated with BP among those subjects without prevalent CHD and those not taking antihypertensive medication (/3-blockers, calcium channel blockers, diuretics, vasodilators, 0-blockers with diuretics, angiotensin converting enzyme inhibitors, angiotensin converting enzyme inhibitors with diuretics, and vasodilators with diuretics), we performed multiple regression analyses for the subgroup without these characteristics (referred to as the "healthier" group) as well as for the entire CHS cohort. Prevalent CHD included having had a myocardial infarction, angina pectoris, or coronary artery bypass graft. Of the 5201 CHS participants, 2287 (44.0%) were taking some form of antihypertensive medication. An additional 432 (8.3%) had prevalent CHD, leaving 2482 participants in the healthier group.
Candidate independent variables for analyses for the entire cohort included clinic site, age, race (black versus nonblack), gender, smoking status, alcohol consumption, height, weight, waist and hip circumferences, heart rate, antihypertensive medication use, diabetes mellitus (defined as either selfreported history of diabetes, being on insulin or oral hypoglycemic medication, fasting blood glucose 2:140 mg/dL, or 2-hour postglucose load 2:200 mg/dL), and renal disease (defined as serum creatinine 2:1.5 mg/dL). Blood analysis variables included white blood cell count, hemoglobin, hematocrit, glucose, insulin, albumin, potassium, uric acid, creatinine, fibrinogen, factor VII, factor VIII, as well as total, high-density lipoprotein, and low-density lipoprotein cholesterol. Carotid ultrasound variables included common and internal carotid artery wall thicknesses (average of the maximal thicknesses) and maximum percent stenosis. ECG-measured variables included presence of LVH, atrial fibrillation, ventricular conduction defect, or any other major ECG abnormalities including Q wave abnormalities or isolated ST-T wave abnormalities. Echocardiographic variables included left ventricular mass (LVM), left atrial dimension, and aortic root dimension (from M-mode); left ventricular ejection fraction (from two-dimensional); and Doppler mitral late peak flow velocity, early peak flow velocity, and early/late peak velocity. Tests of pulmonary function included forced expiratory volume in 1 second and forced vital capacity.
Stepwise linear regression analysis was used to determine, from among the many candidate variables, the best independent predictors of BP. Tests for interactions of age, race, clinic, and gender with the other variables yielded no important interactions. For the linear regression of age on BP, age was treated as if it were measured to the accuracy of 1 year through age 90 (all subjects older than 90 years were combined as a 90-year value for this test only). The lack-of-fit test was used to 
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Une graph shows mean blood pressure by age, the Cardiovascular Health Study. Age group 90 years includes subjects 90 and older. Except for the 90+ age group for men, each age group over 85 years has a sample size of less than 20. SBP indicates systolic blood pressure; DBP, diastolic blood pressure.
test whether the linear regression provided a good fit to the data. 15 Stepwise regression was used to select the variables providing the "best-fitting" equation. Entry into the equations was restricted to variables whose partial F test was significant at the level of P<.01. Where indicated, a quadratic or log term was added to the model. The regression analyses included only those participants with complete data on all variables. Echocardiographic measurements were available in only about two thirds of the participants because of technical difficulties associated with obtaining these measures in elderly people. Thus, the multivariate analyses are done on a sample of the cohort. However, analyses excluding echocardiographic variables yielded similar results for the remaining variables.
In all regression analyses we included for possible entry height, weight, and body mass index (kilogTams per square meter). In no instance was body mass index a significant predictor of either SBP or DBP once height or weight entered into the equation.
Results
A total of 5201 subjects aged 65 to 101 years (mean age, 73) participated in the CHS baseline examination. Of these, 1835 were 65 to 69 years old, 1616 were 70 to 74 years old, 1061 were 75 to 79 years old, and 689 were 80 years or older. Seated DBP values were obtained for 5143 (98.9%) participants and SBP values for 5149 (99.0%) participants. Of these, 4901 (95.3%) were white and 2235 (43.5%) were men. Mean DBP was 69.0 mm Hg for women and 71.6 mm Hg for men; mean SBP was 136.1 mm Hg for women and 135.3 mm Hg for men. There was a linear association between age and both DBP and SBP for both men and women in the entire cohort ( Figure) (correlation coefficients of .20 for SBP and -.09 for DBP, P<.0001 for both). No significant departure from linearity was seen for either SBP or DBP with age for either gender (Figure) . With advancing age, mean SBP increased and mean DBP decreased. The standard deviation of BP generally increased with age, ie, from 19.4 to 24.7 mm Hg for SBP in the 65 versus 90+ group. A test for homogeneity of variances was statistically significant (P<.0001).
About one fourth of the participants had prevalent CHD, 2% had congestive heart failure (CHF), and about 6% had cerebrovascular disease. Approximately 8% had a history of myocardial infarction, 12% reported angina pectoris, and 22% were classified as diabetic (see "Methods" for definitions). Forty-four percent were on antihypertensive medication, and 12% were current smokers. Blacks had significantly higher BP than nonblacks (Table 1) . Men had significantly higher DBP than women, but no gender differences were seen for SBP. Participants who were taking antihypertensive medications had higher mean BP than the group not so medicated. Prevalent CHD and CHF were associated with lower DBP. A history of cerebrovascular disease was associated with significantly lower DBP and higher SBP among subjects without carotid artery stenosis (defined as at least 50% stenosis) and a higher SBP among those with carotid stenosis. Subjects with diabetes mellitus had higher SBP than those without, and compared with nonsmokers, current smokers had significantly lower SBP.
An overview of results of the stepwise regression analyses is shown in Table 2 . Numerical results are presented in Tables 3 and 4 for all participants combined. After the effect of other independent variables was taken into account, participants in Washington County had significantly lower BP (6 to 7 mm Hg) compared with the other clinics. A history of high BP was associated with higher pressures (5.5 mm Hg DBP and 12.5 mm Hg SBP); however, being on antihypertensive medication was associated with lower BP. Black race, male gender, history of hypertension, aortic root dimension, heart rate, hematocrit, creatinine, and alcohol use were positively related to DBP for the total cohort, whereas the ratio of early to late mitral peak flow velocity, carotid artery wall thickness, white blood cell count, and cigarette smoking were inversely related. Maximum percent carotid stenosis was included as a candidate independent variable but was not a significant predictor once the effect of carotid wall thickness was taken into account. Age and black race were independent predictors of DBP, with 1 year of age associated with 0.19 mm Hg lower pressure, and black race with 3 mm Hg higher pressure than nonblack race.
As seen in Table 4 , age, mitral late peak flow velocity, LVM, LVH, common carotid artery wall thickness, diabetes mellitus, intermittent claudication, albumin, factor VII, and alcohol use were all positively related to SBP. Residing in Washington County and Sacramento County was associated with lower and higher SBP, respectively. Prevalent CHD, height, uric acid, and smoking were negatively related to SBP. A slight curvature in the relation between common carotid wall thickness and SBP was seen; ie, SBP increased at a slightly slower rate with increasing wall thickness than could be modeled by a linear term alone. This relation was adequately modeled by adding a quadratic term of wall thickness to the equation .  Tables 5 and 6 show results of the regression analyses for the healthier group. Associations similar to those seen for the whole cohort were found for the relation between DBP and age, early/late mitral peak flow velocity, heart rate, hematocrit, creatinine, and smoking. Additional significant predictors were serum albumin and potassium (negatively related). Compared with analyses including all participants, mitral late peak flow velocity, diabetes mellitus, intermittent claudication, uric acid, height, smoking, and alcohol use were not significantly related to SBP for the healthier group. As seen for DBP, serum potassium was an additional predictor variable.
The variation in BP that could be explained by the predictor variables for the entire cohort was 19% for DBP and 23% for SBP, and, for the healthier group, 16% and 18%, DBP and SBP, respectively.
Discussion
Although SBP increases with age throughout the life span, both cross-sectional and longitudinal analyses have previously identified a decline in DBP after age 50 to 60. 16 Our cross-sectional data suggest that this decline continues through age 90. Much of the systolic hypertension seen in elderly subjects probably results from degenerative changes in the large arterial blood vessels. 17 In youth, the elasticity of these vessels allows them to become distended during systole, but aging is usually accompanied by calcification and decreased elasticity. A given stroke volume therefore results in a greater increase in SBP in old age than in youth. The decrease in elasticity results in less energy being stored in the elastic vessels and less vessel recoil during diastole, resulting in less blood flow during diastole and thus a lower DBP. Our finding of a greater within-person variation in BP with increasing age is supported by results from the Hypertension Detection and Follow-up Program, 18 suggesting that even when one allows for differences in absolute levels, within-person variation in BP usually increases with age.
In univariate analysis, DBP was lower among subjects with prevalent CHD, CHF, and cerebrovascular disease, and SBP was lower among those with CHF. These associations may seem contradictory to known associa- tions between BP and cardiovascular disease. There are several likely explanations: myocardial damage or dysfunction associated with CHD and CHF causes reduced cardiac output and lowered BP; hypertension would likely be aggressively treated in these individuals, resulting in lower BP; many medications given for these conditions, such as /3-blockers and vasodilators, lower BP; and although the results of the Systolic Hypertension in the Elderly Program indicate that systolic hypertension is causally related to stroke and CHD in the elderly, 17 perhaps DBP does not have the same risk as in younger populations, given the fact that older people tend to have lower DBP. Another possibility is that people with higher DBP die before reaching old age.
In univariate analysis, subjects on antihypertensive medications have higher BP values than those not so medicated; that is, medication does not lower BP to the same level as in those not taking antihypertensive medication. However, when the variable "history of hypertension" was adjusted for in multivariate analyses, being on antihypertensive medication was in itself associated with lower BP (Tables 3 and 4) . Thus, the variable "antihypertensive medication use" is measuring the contribution of the use of medications above and beyond the effect of hypertension itself.
The positive relation between ECG evidence of LVH and SBP is consistent with previous observations. relation to SBP. Neither of these parameters correlated as strongly with DBP, a finding also noted in the Framingham cohort. 20 When subjects with CHD or on antihypertensive medications were excluded, the ECG evidence of LVH did not correlate significantly with SBP, whereas the echocardiographic estimate of LVM retained its significant relation. This positive relation of BP with echocardiographic estimates of LVM is consistent with observations made in the Framingham Heart Study cohort. 20 The apparent discordance between ECG and echocardiographic estimates of LVH could be due to a lower sensitivity of ECG in detecting increased left ventricular wall thickness, as well as an underrepresentation in the CHS of individuals with diseaseassociated LVH.
When all participants were included, impairment of diastolic function of the left ventricle as assessed by Doppler was associated with DBP but not with SBP. The absence of a significant relation with SBP has also been noted in younger people. 21 Late peak flow velocity across the mitral valve was positively related to SBP in both the full cohort and the healthier group. It is interesting that these changes in diastolic function of the ventricle are present despite the absence of diagnosed or manifest CHD, a known cause of impaired early diastolic filling.
Although in middle-aged populations both DBP and SBP have been associated with carotid artery wall thickness, 22 in the CHS, mean carotid artery wall thickness was positively related to SBP and negatively related to DBP. This phenomenon could be explained by decreasing compliance of vessel walls with advancing age, leading to increased pulse pressure. Previous studies of middle-aged adults have found positive associations of heart rate with DBP and SBP in both cross-sectional and longitudinal studies. 23 ' 24 In our study of older adults, heart rate was independently related to DBP but not to SBP. These results are consistent with findings in the Second National Health Examination Survey, which included subjects up to 74 years and in which resting heart rate was independently associated with DBP and SBP only in the age groups younger than 55 years. 25 The role of body weight as a predictor of BP seems to diminish with advancing age. 26 In a study of men and women older than 75 years, body weight was significantly related to DBP in women only after controlling for other potential risk factors for high BP. 27 In the CHS, body weight was a positive predictor (independent of height) of DBP only in the healthier group. Height was inversely related to SBP in the entire cohort, whereas weight did not enter the final model. The effect of height was small, -0.19 mm Hg/cm. This finding is interesting because a direct association of height and BP has been previously reported in younger populations. 28 -29 Serum albumin was independently related to both DBP and SBP in the subgroup without hypertension and CHD and with SBP only for all participants combined. The effect was strongest for SBP, where an .0001
y Indicates yes (=1); n, no (=0). The "healthier" subgroup does not include participants taking antihypertensive medication and/or with prevalent coronary heart disease, ft 2 =.16. 'Natural logarithm.
increase of 1 mg/dL in serum albumin was associated with more than 10 mm Hg greater pressure in the healthier subgroup. A positive relation between serum albumin and SBP but not DBP has been previously reported. 30 ' 32 A significant relation between total serum protein and BP, independent of the effects of body weight, heart rate, and alcohol consumption, has also been described. 33 The positive relation between serum albumin and BP is not fully understood. It has been reported that untreated patients with essential hypertension have normal plasma albumin concentration and reduced plasma volume whereas the intravascular albumin mass is reduced. 34 Because serum albumin concen- .0004
y indicates yes (=1); n, no (=0). The "healthier" subgroup does not Include participants taking antihypertensive medication and/or with prevalent coronary heart disease. ft 2 =.2O. *Echocardiographic measurement. tAverage of the maximum near and far walls, right and left sides (four measurements).
tration affects intravascular osmotic pressure, 35 -36 an increased plasma albumin concentration could be an expression of hemoconcentration, ie, decreased plasma volume, based on transcapillary escape of water into interstitial or intracellular compartments as shown in animal experiments. 37 The significant correlation between SBP and albumin concentration, as well as a reported positive correlation between albumin and hematocrit, lends support to this explanation. 30 Consistent with other studies, 32 we found an independent positive effect of hematocrit on DBP, with a 1% difference in hematocrit corresponding to an average increment of 0.35 mm Hg. A stronger correlation between hematocrit and DBP than SBP also has been reported by others.
-
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' 39 Decreased plasma volume may account for the association between hematocrit and BP. In fact, serum albumin and hematocrit may be only indirect indicators of some other more fundamental relation to BP that likely involves plasma volume. If one postulates a decreasing plasma volume with increasing BP, these findings seem logical.
Renal dysfunction is a well-known consequence and cause of high BP in younger populations. Creatinine, although an insensitive measure of renal function, was strongly associated with higher DBP in both the full CHS cohort and the healthier group with, respectively, 2.3 and 3.7 mm Hg increases in DBP for each milligram per deciliter increase in creatinine. Serum potassium was inversely related to both DBP and SBP in the cohort without hypertension and CHD. A negative association between serum (or plasma) potassium and both DBP and SBP 40 or with DBP only 31 - 41 has been previously observed. There is a well-documented relation between average alcohol intake and elevated BP 42, 43 a n ( j t m s association was confirmed in the CHS among the entire cohort. Smoking was inversely related to BP, consistent with findings from previous studies among young and middle-aged adults. 44 Clinic site was a strong predictor of both DBP and SBP, with participants in Washington County having significantly lower BP compared with the other sites. This difference between sites could reflect a real difference in BP values or could be due to technician effects. The latter explanation is unlikely because this difference was found for several technicians at that site and because one of the CHS investigators (G.H.R.) reviewed the Washington County field center technicians, including taking simultaneous BPs, and was unable to find any deviation from protocol. A search for differences in characteristics of the Washington County population offered no explanations, and statistical adjustments for race, disease status, and medical treatment did not diminish this difference. Because there is no a priori reason to believe that mean BP values should be the same in every part of the country, the differences are probably real.
In conclusion, results from the baseline examination of the CHS confirm some relations to BP previously reported in middle-aged populations. In addition, our study has revealed important new information on correlates of BP, including the association of lower SBP with prevalent cardiovascular disease, as well as the relation of BP to cardiac anatomy and functions, carotid artery variables, and blood chemistry including serum albumin. Our results also underscore the importance of
